NCT07197554
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07197554
Title A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies
Recruitment Not yet recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors SEED Therapeutics, Inc.
Indications
Therapies
Age Groups: adult | child | senior
Covered Countries USA


No variant requirements are available.